ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

EPC Edgewell Personal Care Company

37.82
-0.15 (-0.40%)
04 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Edgewell Personal Care Company NYSE:EPC NYSE Common Stock
  Price Change % Change Share Price High Price Low Price Open Price Shares Traded Last Trade
  -0.15 -0.40% 37.82 38.40 37.67 38.29 237,417 01:00:00

Statement of Changes in Beneficial Ownership (4)

05/03/2019 9:12pm

Edgar (US Regulatory)


FORM 4
[ X ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

HATFIELD DAVID P
2. Issuer Name and Ticker or Trading Symbol

EDGEWELL PERSONAL CARE Co [ EPC ]
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__ X __ Director                      _____ 10% Owner
_____ Officer (give title below)      _____ Other (specify below)
(Last)          (First)          (Middle)

C/O EDGEWELL PERSONAL CARE COMPANY, 1350 TIMBERLAKE MANOR PARKWAY
3. Date of Earliest Transaction (MM/DD/YYYY)

3/1/2019
(Street)

CHESTERFIELD, MO 63017
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock   3/1/2019     M    52238   (1) A $0.00   104615   I   Shares owned by Joint Trust  
Common Stock                  18619   D    

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Equivalent 11/3/2016   $0.00   3/1/2019     J         992      (2)   (2) Common Stock   992   $0.00   3470   (3) D    
Non-Qualified Stock Options 11/3/2016   $74.70   3/1/2019     J         3711      (2)   (2) Common Stock   3711   $0.00   12989   (4) D    
Performance Stock Equivalents 11/3/2016   $0.00   3/1/2019     J         4462      (2)   (2) Common Stock   4462   $0.00   15619   (5) D    
Restricted Stock Equivalent 11/13/2017   $0.00   3/1/2019     J         4981      (2)   (2) Common Stock   4981   $0.00   6225   (3) D    
Non-Qualified Stock Options 11/13/2017   $58.90   3/1/2019     J         12005      (2)   (2) Common Stock   12005   $0.00   15005   (4) D    
Performance Stock Equivalents 11/13/2017   $0.00   3/1/2019     J         31127      (2)   (2) Common Stock   31127   $0.00   24901   (6) D    
Restricted Stock Equivalents 11/15/2018   $0.00   3/1/2019     J         23180      (2)   (2) Common Stock   23180   $0.00   0   D    
Non-Qualified Stock Options 11/15/2018   $42.71   3/1/2019     J         50887      (2)   (2) Common Stock   50887   $0.00   0   D    
Performance Stock Equivalents 11/15/2018   $0.00   3/1/2019     J         241162      (2)   (2) Common Stock   241162   $0.00   0   D    

Explanation of Responses:
(1)  Previously deferred Restricted Stock Equivalents converted into shares of Edgewell common stock due to Mr. Hatfield's departure from the Company on March 1, 2019. These shares of Edgewell common stock will be delivered to Mr. Hatfield on September 3, 2019.
(2)  Unvested award forfeited upon Mr. Hatfield's departure from the Company on March 1, 2019.
(3)  These shares vested upon Mr. Hatfield's departure from the Company on March 1, 2019. These shares will be delivered to Mr. Hatfield on September 3, 2019.
(4)  These options vested upon Mr. Hatfield's departure from the Company. He will have 5 years from his departure date to exercise them.
(5)  These PSEs will vest and convert into shares of Edgewell common stock upon the release of earnings for fiscal year ending September 30, 2019 if specified performance criteria are met subject to the exercise of negative discretion by the Compensation Committee of Edgewell's Board of Directors. The performance goal for the PSEs is the adjusted earnings per share of the Company for its 2019 fiscal year.
(6)  These PSEs will vest and convert into shares of Edgewell common stock upon the release of earnings for fiscal year ending September 30, 2020 if specified performance criteria are met subject to the exercise of negative discretion by the Compensation Committee of Edgewell's Board of Directors. The performance goal for the PSEs are the adjusted earnings per share of the Company for its 2020 fiscal year and the adjusted cumulative free cash flow of the Company for its 2020 fiscal year as a percentage of adjusted net sales of the Company for its 2020 fiscal year.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
HATFIELD DAVID P
C/O EDGEWELL PERSONAL CARE COMPANY
1350 TIMBERLAKE MANOR PARKWAY
CHESTERFIELD, MO 63017
X



Signatures
Marisa Iasenza, Attorney-in-Fact 3/4/2019
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

1 Year Edgewell Personal Care Chart

1 Year Edgewell Personal Care Chart

1 Month Edgewell Personal Care Chart

1 Month Edgewell Personal Care Chart

Your Recent History

Delayed Upgrade Clock